US Patent Issued to INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE on July 8 for "Tetrasaccharides for the diagnosis, prevention, and treatment of melioidosis and glanders" (Canadian Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,596, issued on July 8, was assigned to INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Quebec, Canada).

"Tetrasaccharides for the diagnosis, prevention, and treatment of melioidosis and glanders" was invented by Charles Gauthier (Laval, Canada) and Maude Cloutier (Windsor, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tetrasaccharide of formula I and a method of production thereof are provided. Furthermore, a conjugate comprising the tetrasaccharide and a molecule attached to the tetrasaccharide, preferably via its amine group, is also provided. Compositions, preferably immunogenic or vaccine compositions, comprising this tetrasaccharide or...